1Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP --specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res,1996,8(2) :47-52.
2Leuchte HH, Schwaiblmair M, Baumgartner RA, et al. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Chest, 2004, 125 : 580-586.
3Michelakis E ,Tyrnchak W ,Lien D, et al. Oral sildenafil is an effective and specific pulmonary vasodilatro in Patients with pulmonary arterial hypertension : comparison with inhaled nitric oxide. Circulation, 2002,105: 2 398- 2 403.
4Aldashev AA, Kojonazarov B K, Amatov TA, et al. Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax, 2005,60 (8) : 683-687.
5Hsu AR , Barnholt KE, Grundmann NK , et al. sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. J Apple Physiol, 2006, 100(6) :2 031-2 040.
6[1]Ghofrani HA,Reichenberger F,Kohstall MC,et al.Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp:a randomized,double-blind,placebo-controlled crossover trial[J].Ann Intern Med,2004,141:169～177.
7[3]Aldashev AA,Kojonazarov BK,Amatov TA,et al.Phosphodiesterase type 5 and high altitude pulmonary hypertension[J].Thorax,2005,60(8):683～687.
8[4]Weimann.J,Ullrich R,Hromi J,et al.Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hyperten-sion[J].Anesthesiology,2000,92:1702～1712.
9[5]Ralph T.Schermuly,Klaus P.Kreisselmeier,Hossein A.Ghofrani,et al.Chromic sildenafil treatment inhibits monocrotalin-induce pulmonary hypertension in rats[J].Am J Respir Crit Care Med,2004,169:39～45.
10[6]Hsu AR,Barnholt KE,Grundmann NK,et al.Sildenafil improves cardiac output and exercise performance during acute hypoxia,but not normoxia[J].J Appl Physio,2006,100(6):2031～2040.
